Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update on Antiepileptic Drugs 2019
Bassel Abou‐Khalil
CONTINUUM Lifelong Learning in Neurology (2019) Vol. 25, Iss. 2, pp. 508-536
Closed Access | Times Cited: 122

Showing 1-25 of 122 citing articles:

Gamma-aminobutyric acid and probiotics: Multiple health benefits and their future in the global functional food and nutraceuticals market
Lucía Diez-Gutiérrez, Leire San Vicente, Luis Javier R. Barrón, et al.
Journal of Functional Foods (2019) Vol. 64, pp. 103669-103669
Open Access | Times Cited: 189
Therapeutic Strategies to Ameliorate Neuronal Damage in Epilepsy by Regulating Oxidative Stress, Mitochondrial Dysfunction, and Neuroinflammation
Sahithi Madireddy, Samskruthi Madireddy
Brain Sciences (2023) Vol. 13, Iss. 5, pp. 784-784
Open Access | Times Cited: 42
Neuropsychiatric Systemic Lupus Erythematosus: Molecules Involved in Its Imunopathogenesis, Clinical Features, and Treatment
Angel A Justiz-Vaillant, Darren Gopaul, Sachin Soodeen, et al.
Molecules (2024) Vol. 29, Iss. 4, pp. 747-747
Open Access | Times Cited: 25
Recent advances in the biosynthesis and industrial biotechnology of Gamma-amino butyric acid
Ripon Baroi Milon, Pengchen Hu, Xueqiong Zhang, et al.
Bioresources and Bioprocessing (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 10
Presynaptic dysfunction in neurodevelopmental disorders: Insights from the synaptic vesicle life cycle
Katherine Bonnycastle, Elizabeth C. Davenport, Michael A. Cousin
Journal of Neurochemistry (2020) Vol. 157, Iss. 2, pp. 179-207
Open Access | Times Cited: 67
Elucidating the Potential Side Effects of Current Anti-Seizure Drugs for Epilepsy
Enes Akyüz, Betül Köklü, Cansu Ozenen, et al.
Current Neuropharmacology (2021) Vol. 19, Iss. 11, pp. 1865-1883
Open Access | Times Cited: 43
Treatment and care of women with epilepsy before, during, and after pregnancy: a practical guide
Bruna Nucera, Francesco Brigo, Eugen Trinka, et al.
Therapeutic Advances in Neurological Disorders (2022) Vol. 15
Open Access | Times Cited: 34
Molecular mechanisms of topiramate and its clinical value in epilepsy
Yun-Fei Bai, Chang Zeng, Miaomiao Jia, et al.
Seizure (2022) Vol. 98, pp. 51-56
Open Access | Times Cited: 28
Intellectual Disability and Potassium Channelopathies: A Systematic Review
Miriam Kessi, Baiyu Chen, Jing Peng, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 41
Antiseizure Drugs and Movement Disorders
Michel Sáenz‐Farret, Marina A.J. Tijssen, Dawn Eliashiv, et al.
CNS Drugs (2022) Vol. 36, Iss. 8, pp. 859-876
Closed Access | Times Cited: 23
Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events
Emily K. Acton, Sean Hennessy, Michael Gelfand, et al.
JAMA Neurology (2024) Vol. 81, Iss. 8, pp. 835-835
Closed Access | Times Cited: 5
Navigating Drug-Resistant Epilepsy: A Case Report on Achieving Seizure Freedom for 5 Years with Perampanel Therapy in a Patient with Multiple Comorbidities
Anas Mohammad Albarrak, Saleh Algarni, Seyed M. Mirsattari
International Journal of Pharmacology (2025) Vol. 21, Iss. 1, pp. 150-154
Closed Access
Impact of phenytoin and valproic acid on cytotoxicity and inflammatory mediators in human mononuclear cells: with and without lipopolysaccharide stimulation
Aminah Alesawy, Norah Alotaibi, Marwa Alalshaikh, et al.
PeerJ (2025) Vol. 13, pp. e19102-e19102
Open Access
The Effect of Plasma Protein Binding on the Therapeutic Monitoring of Antiseizure Medications
Bruno Charlier, Albino Coglianese, Federica De Rosa, et al.
Pharmaceutics (2021) Vol. 13, Iss. 8, pp. 1208-1208
Open Access | Times Cited: 29
Co-crystallization in Antiepileptic Drugs: A Path Toward Better Therapeutic Outcomes
B. N. Patil, Sanjay J. Surana, Atul A. Shirkhedkar
Cureus (2025)
Open Access
Epileptogenesis and oncogenesis: An antineoplastic role for antiepileptic drugs in brain tumours?
Federico Cucchiara, Francesco Pasqualetti, Filippo Sean Giorgi, et al.
Pharmacological Research (2020) Vol. 156, pp. 104786-104786
Closed Access | Times Cited: 28
Update on first unprovoked seizure in children and adults: A narrative review
María José Jimenez-Villegas, Lucas Lozano-García, Jaime Carrizosa
Seizure (2021) Vol. 90, pp. 28-33
Open Access | Times Cited: 24
Quinazoline: An update on current status against convulsions
Rameshwar S. Cheke, Sachin D. Shinde, Jaya P. Ambhore, et al.
Journal of Molecular Structure (2021) Vol. 1248, pp. 131384-131384
Closed Access | Times Cited: 24
Antiseizure medication discovery: Recent and future paradigm shifts
Alan Talevi
Epilepsia Open (2022) Vol. 7, Iss. S1
Open Access | Times Cited: 16
Hypothermia combined with neuroprotective adjuvants shortens the duration of hospitalization in infants with hypoxic ischemic encephalopathy: Meta-analysis
Andrea Ovcjak, Riley Pontello, Steven P. Miller, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 9
Experimental GABA A Receptor Agonists and Allosteric Modulators for the Treatment of Focal Epilepsy
Slobodan Јаnkovic, Miralem Dješević, Snežana V. Janković
Journal of Experimental Pharmacology (2021) Vol. Volume 13, pp. 235-244
Open Access | Times Cited: 22
Management of COVID-19 in patients with seizures: Mechanisms of action of potential COVID-19 drug treatments and consideration for potential drug-drug interactions with anti-seizure medications
Shreshta Jain, Heidrun Potschka, P. Prarthana Chandra, et al.
Epilepsy Research (2021) Vol. 174, pp. 106675-106675
Open Access | Times Cited: 21
EEG-Driven Prediction Model of Oxcarbazepine Treatment Outcomes in Patients With Newly-Diagnosed Focal Epilepsy
Bin Wang, Xiong Han, Zongya Zhao, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 15
Dysfunction of ABC Transporters at the Surface of BBB: Potential Implications in Intractable Epilepsy and Applications of Nanotechnology Enabled Drug Delivery
Roohi Mohi-ud-din, Reyaz Hassan Mir, Prince Ahad Mir, et al.
Current Drug Metabolism (2022) Vol. 23, Iss. 9, pp. 735-756
Closed Access | Times Cited: 14
Synthesis, Characterization, In Silico and In Vivo Evaluation of Benzimidazole‐Bearing Quinoline Schiff Bases as New Anticonvulsant Agents
Km Shabana, Salahuddin Salahuddin, Avijit Mazumder, et al.
ChemistrySelect (2023) Vol. 8, Iss. 21
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top